Protein A Sepharose CL-4B antibody purification filler

NegotiableUpdate on 01/02

Model

Nature of the Manufacturer: Producers

Product Category

Place of Origin

Online Consult

Overview

Protein A Sepharose CL-4B antibody purification filler is a reliable and well documented affinity filler that can be used in immunoprecipitation programs. It can also be used for antibody purification.

Product Details

Protein A Sepharose CL-4B antibody purification filler

Protein A Sepharose CL-4B is a reliable and well documented affinity filler that can be used in immunoprecipitation programs. It can also be used for antibody purification.

A high binding load of 20 mg human IgG/mL.

High selectivity and low non-specific adsorption.

Very suitable for immunoprecipitation procedures.

Used for immunoprecipitation program

Protein A Sepharose CL-4B filler has high specificity and high loading capacity, making it reliable for precise and reproducible immunoprecipitation procedures - whether the ultimate goal is to determine protein mass, analyze protein interactions, or evaluate post-translational modifications.

Successfully used for published research

This protein A filler can be used for various applications, including:

Regulating epithelial cell migration promoted by MYO18A, a member of the myosin superfamily

Study the role of protein hydrophobicity in regulating endoplasmic reticulum

Product ordering:

17096303 Protein A Sepharose CL-4B, 25 mL 25 mL

17096302 Protein A Sepharose CL-4B, 500 mL 500 mL

17078001 Protein A Sepharose CL-4B, 1.5 g 1.5 g

Shanghai Xiyan Scientific Instrument Co., Ltd. acts as an agent for the distribution of Cytiva/Situofan (formerly GE General) products,

Cytiva, formerly known as GE Healthcare Life Sciences, is now part of the life sciences platform under the Danaher Group. As a pioneer in the global life sciences field, Cytiva is committed to promoting and accelerating the development of global healthcare. Cytiva has annual sales exceeding 3.3 billion US dollars and employs nearly 7000 people in over 40 countries worldwide. As a trusted partner, Cytiva comprehensively assists customers in improving the speed, efficiency, and capabilities of research and production processes, empowering the development and production of innovative drugs, and benefiting patients worldwide.

AKTA's product line focuses on protein purification products and is a leader in the industry; The Biacore product line focuses on studying the interactions of biomolecules and has been included in the pharmacopoeias of the United States and Japan; Amersham's product line focuses on protein and nucleic acid consumables; Ficoll/Percoll product line focuses on cell separation density gradient products; In addition, Whatman filter paper, Hyclone culture medium, BioTrak immunolabeling consumables, Sera Mag immunomagnetic beads, Wave bioreactors and Excellerex fermenters, hollow fiber and membrane filtration systems and units are also highly recognized by the industry.

Cytiva provides complete solutions for pharmaceutical companies to reduce the time and cost of new drug screening and development, quickly and simply convert research results into large-scale production, and better select effective and safe drug development solutions from drug development candidates to develop new drugs faster, paving the way for major breakthroughs in the field of pharmaceutical research and development.

For over 100 years, scientists and researchers from academia, industry, and various fields have maintained long-term and good cooperation with Cytiva, focusing on technology research and development and improving productivity. No matter what challenges you face in the healthcare system and basic life research, you can obtain high-quality products and outstanding and systematic services and support through Cytiva.

The information is sourced from the internet. If there is any infringement, please contact us for deletion.